8-K
filed March 10, 2026, 7:59 PM ET
ticker DMRA
CIK 0001800315
other material
confidence high
sentiment positive
materiality 0.70
Galecto rebrands as Damora Therapeutics (DMRA); $535M cash; DMR-001 IND mid-2026
Damora Therapeutics, Inc.
- Name changed from Galecto to Damora Therapeutics; trades on Nasdaq as DMRA from March 10, 2026.
- Preliminary cash and cash equivalents ~$535M as of Feb 28, 2026, including ~$316M from Feb 2026 public offering.
- DMR-001 (anti-mutCALR antibody) IND/CTA on track for mid-2026; proof-of-concept data expected mid-2027.
- DMR-002 IND/CTA planned for H2 2026; DMR-003 IND/CTA in 2027.
- Acquisition of privately held Damora closed Nov 2025 with ~$285M private investment.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001193125-26-099404
- form_type
- 8-K
- ticker
- DMRA
- cik
- 0001800315
- company_name
- Damora Therapeutics, Inc.
- filed_at
- 2026-03-10T23:59:59+00:00
- discovered_at
- 2026-05-14T18:02:36.216030+00:00
- generated_at
- 2026-05-15T16:51:12.833824+00:00
- sec_items
- ["2.02", "5.03", "7.01", "9.01"]
- event_type
- other_material
- sentiment
- positive
- materiality_score
- 0.7
- calibrated_materiality_score
- 0.7
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001193125-26-099404
- json_url
- https://secwatch.observer/filing/0001193125-26-099404.json
- markdown_url
- https://secwatch.observer/filing/0001193125-26-099404.md
- text_url
- https://secwatch.observer/filing/0001193125-26-099404.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1800315/000119312526099404/0001193125-26-099404-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1800315/000119312526099404/dmra-20260306.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
WAMFF
Alaska Silver simplifies capital structure, eliminates dual-class shares
Alaska Silver Corp.
May 7, 2026, 7:59 PM ET
other_material
Items 3.03, 5.03, 7.01, 9.01
same fact type: governance_change
same SEC item: 5.03, 7.01, 9.01
same event type: other_material
similar materiality
This filing
On March 6, 2026, the Company filed with the Secretary of State of the State of Delaware an amendment to its Amended and Restated Certificate of Incorporation to change the name of the Company from "Galecto, Inc." to "Damora Therapeutics, Inc." (the "Name Change Amendment"). The Name Change Amendment became effective at 12:01 a.m. Eastern Time on March 10, 2026.
Comparable filing
On May 6, 2026, the Board of Directors of Alaska Silver Corp. (the "Company"), approved an amendment (the "Amendment") to the Company's Articles of the Company to eliminate its dual-class share structure by (i) eliminating its proportionate voting share class and (ii) reidentifying its subordinate voting share class as the class of "Common Shares," no par value, of which the Company shall be authorized to issue an unlimited number of Common Shares.
Filing page
SEC filing
CUK
Carnival completes DLC unification and redomiciliation to Bermuda; Carnival plc now a subsidiary
CARNIVAL PLC
May 7, 2026, 7:59 PM ET
other_material
Items 1.02, 2.01, 3.01, 3.02, 3.03, 5.01, 5.03, 7.01, 9.01
same fact type: governance_change
same SEC item: 5.03, 7.01, 9.01
same event type: other_material
similar materiality
This filing
On March 6, 2026, the Company filed with the Secretary of State of the State of Delaware an amendment to its Amended and Restated Certificate of Incorporation to change the name of the Company from "Galecto, Inc." to "Damora Therapeutics, Inc." (the "Name Change Amendment"). The Name Change Amendment became effective at 12:01 a.m. Eastern Time on March 10, 2026.
Comparable filing
In addition, Carnival Corporation also migrated its jurisdiction of incorporation from the Republic of Panama to Bermuda and changed its name to "Carnival Corporation Ltd." (the "Redomiciliation" and, together with the DLC Unification, the "DLC Unification and Redomiciliation Transactions").
Filing page
SEC filing
ENZN
Viskase Holdings adopts Section 382 Rights Plan to protect NOL assets; threshold at 4.9%
Viskase Holdings, Inc.
May 5, 2026, 7:59 PM ET
other_material
Items 1.01, 3.03, 5.03, 7.01, 9.01
same fact type: governance_change
same SEC item: 5.03, 7.01, 9.01
same event type: other_material
similar materiality
This filing
On March 6, 2026, the Company filed with the Secretary of State of the State of Delaware an amendment to its Amended and Restated Certificate of Incorporation to change the name of the Company from "Galecto, Inc." to "Damora Therapeutics, Inc." (the "Name Change Amendment"). The Name Change Amendment became effective at 12:01 a.m. Eastern Time on March 10, 2026.
Comparable filing
In connection with the adoption of the Section 382 Rights Agreement, the Board approved a Certificate of Designation of Series A-2 Junior Participating Preferred Stock of Viskase Holdings, Inc. (the “Certificate of Designation”). The Certificate of Designation was filed with the Secretary of the State of Delaware on May 5, 2026.
Filing page
SEC filing
MTNE
CH4 Natural Solutions Corporation prices $200M IPO; begins trading on NYSE
CH4 Natural Solutions Corp
May 5, 2026, 7:59 PM ET
other_material
Items 1.01, 3.02, 5.02, 5.03, 7.01, 8.01, 9.01
same fact type: governance_change
same SEC item: 5.03, 7.01, 9.01
same event type: other_material
similar materiality
This filing
On March 6, 2026, the Company filed with the Secretary of State of the State of Delaware an amendment to its Amended and Restated Certificate of Incorporation to change the name of the Company from "Galecto, Inc." to "Damora Therapeutics, Inc." (the "Name Change Amendment"). The Name Change Amendment became effective at 12:01 a.m. Eastern Time on March 10, 2026.
Comparable filing
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year. The Company’s Amended and Restated Memorandum and Articles of Association (as so amended, the “ Memorandum and Articles ”) were approved on April 30, 2026.
Filing page
SEC filing
INHD
Inno Holdings to effect 1-for-20 reverse stock split on May 4, 2026 for Nasdaq compliance
INNO HOLDINGS INC.
May 4, 2026, 7:59 PM ET
other_material
Items 5.03, 7.01, 9.01
same fact type: governance_change
same SEC item: 5.03, 7.01, 9.01
same event type: other_material
similar materiality
This filing
On March 6, 2026, the Company filed with the Secretary of State of the State of Delaware an amendment to its Amended and Restated Certificate of Incorporation to change the name of the Company from "Galecto, Inc." to "Damora Therapeutics, Inc." (the "Name Change Amendment"). The Name Change Amendment became effective at 12:01 a.m. Eastern Time on March 10, 2026.
Comparable filing
On April 30, 2026, Inno Holdings Inc., a Texas holding company (the “Company”) filed a Certificate of Amendment to the Certificate of Formations of the Company with the Secretary of State of the State of Texas (the “Certificate of Amendment”) that provides for a 1-for-20 reverse stock split (the “Reverse Stock Split”) of its issued and outstanding shares of common stock, with no par value (the “Common Stock”).
Filing page
SEC filing
CWEN
Clearway Energy eliminates Class A stock; converts all shares to reduced-vote Class C
Clearway Energy, Inc.
May 1, 2026, 7:59 PM ET
other_material
Items 1.01, 3.03, 5.03, 5.07, 7.01, 9.01
same fact type: governance_change
same SEC item: 5.03, 7.01, 9.01
same event type: other_material
similar materiality
This filing
On March 6, 2026, the Company filed with the Secretary of State of the State of Delaware an amendment to its Amended and Restated Certificate of Incorporation to change the name of the Company from "Galecto, Inc." to "Damora Therapeutics, Inc." (the "Name Change Amendment"). The Name Change Amendment became effective at 12:01 a.m. Eastern Time on March 10, 2026.
Comparable filing
Following the Class A Conversion, on May 1, 2026, the Company filed with the Delaware Secretary of State a certificate of retirement pursuant to Section 243 of the DGCL (the “Certificate of Retirement”) to retire all shares of Class A common stock converted in the Class A Conversion, which also had the effect of amending the Amended Charter to (i) reduce the total number of authorized shares of Class A common stock from 34,613,853 to zero, (ii) reduce the total number of authorized shares of capital stock of the Company from 2,544,613,853 to 2,510,000,000 and (iii) eliminate from the Amended Charter all references to the Class A common stock (collectively, the “Class A Retirement”).
Filing page
SEC filing
QXL
Viewbix renamed Quantum X Labs Inc.; Nasdaq ticker changes to QXL
Viewbix Inc.
April 30, 2026, 7:59 PM ET
other_material
Items 5.03, 7.01, 8.01, 9.01
same fact type: governance_change
same SEC item: 5.03, 7.01, 9.01
same event type: other_material
similar materiality
This filing
On March 6, 2026, the Company filed with the Secretary of State of the State of Delaware an amendment to its Amended and Restated Certificate of Incorporation to change the name of the Company from "Galecto, Inc." to "Damora Therapeutics, Inc." (the "Name Change Amendment"). The Name Change Amendment became effective at 12:01 a.m. Eastern Time on March 10, 2026.
Comparable filing
effective April 30, 2026, the Company amended and restated its Amended and Restated Bylaws (the "Bylaws") to reflect the Name Change (the "A&R Bylaws"). The A&R Bylaws contain no other changes.
Filing page
SEC filing
DGAC
Disciplined Growth Acquisition Corp. closes $150M IPO on NYSE
DISCIPLINED GROWTH ACQUISITION Corp
June 1, 2026, 4:15 PM ET
other_material
Items 1.01, 3.02, 5.02, 5.03, 8.01, 9.01
same fact type: governance_change
same SEC item: 5.03, 9.01
same event type: other_material
similar materiality
This filing
On March 6, 2026, the Company filed with the Secretary of State of the State of Delaware an amendment to its Amended and Restated Certificate of Incorporation to change the name of the Company from "Galecto, Inc." to "Damora Therapeutics, Inc." (the "Name Change Amendment"). The Name Change Amendment became effective at 12:01 a.m. Eastern Time on March 10, 2026.
Comparable filing
On May 26, 2026, in connection with the IPO, the Company filed its amended and restated memorandum and articles of association (the “Amended and Restated Memorandum and Articles of Association”) with the Cayman Islands Registrar of Companies, which was effective on May 26, 2026.
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.